KNAW

Back to search results
Prof.dr. J. Verweij Person

Prof.dr. J. Verweij

Pagina-navigatie:


Update Persondata


Export page
Expertise Drug development in oncology; Pharmacology of cytotoxics and cytostatics; Drug interactions; Study design
Expertise (NL) Medicijnontwikkeling binnen de oncologie; Farmacologie van cytostatica; Geneesmiddel-interacties; Studie-ontwerp
Digital Author ID info:eu-repo/dai/nl/072091967
KNAW member Science Division
Addition Bijzonder hoogleraar vanwege de Dr. Daniel den Hoed Stichting; Vice-president EORTC (European Organization for Research and Treatment of Cancer); Vice president CTOS (Connective Tissue Oncology Society)

Active as

Professor
Organisation Department of Internal Oncology (EUR)
Chair (EN) Experimental chemotherapy
Chair (NL) Experimentele chemotherapie
Email j. verweij -at- erasmusmc. nl
URL http://www.knaw.nl/Pages/DEF/27/896.bGFuZz1OTA.html
Dean
Organisation Erasmus University Medical Center Rotterdam (EUR)
Email j. verweij -at- erasmusmc. nl
URL http://www.knaw.nl/Pages/DEF/27/896.bGFuZz1OTA.html

Publications

(the most recent at the top)
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor
A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours
Phase i and pharmacological study of the broad-spectrum tyrosine kinase inhibitor JNJ-26483327 in patients with advanced solid tumours
(Pre-)Clinical pharmacology and activity of pazopanib, a novel multikinase angiogenesis inhibitor
A CYP3A4 phenotype-based dosing algorithm for individualized treatment of irinotecan
All publications..

Completed research projects

(the most recent research is at the top)
Project leader Biological and clinical aspects of drug-resistance and -sensitivity of malignancies

Classification

A34800 Drugs and pesticides
A70000 Public health and health care
D23120 Oncology
D23340 Biopharmacology, toxicology

Go to page top
Go back to contents
Go back to site navigation